Medical research

Simple molecular reagents to treat Alzheimer's disease

Sometimes the most complex problems actually have very simple solutions. A group of South Korean researchers reported an efficient and effective redox-based strategy for incorporating multiple functions into simple molecular ...

Alzheimer's disease & dementia

Teams publish in vivo Alzheimer's disease treatment data

Oligomerix, Inc., a privately held company pioneering the development of tau oligomer inhibitors for Alzheimer's disease (AD) and related neurodegenerative disorders, and the Feinstein Institutes for Medical Research announced ...

page 7 from 37